Breast cancer: Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel
With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
What are the effects (good or bad) of adding a chemotherapy drug called carboplatin
to the usual chemotherapy drugs given after surgery?
Basic Study Information
Purpose:Location: Cancer Center
This study has two study groups.
Group 1 will get the usual chemotherapy drugs used for this type of cancer: doxorubicin
and cyclophosphamide, followed by paclitaxel.
Group 2 will get the usual chemotherapy drugs used for this type of cancer: doxorubicin
and cyclophosphamide, followed by paclitaxel plus the chemotherapy drug called carboplatin.
Study Web URL: https://clinicaltrials.gov/ct2/show/NCT02488967?term=Br003&rank=2
Study Reference #: CBRS-16091
Lead Researcher (Principal Investigator)
Lead Researcher: Allison Magnuson
Study Contact InformationStudy Coordinator: Kate Corcoran
Phone: (585) 275-7771
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search